{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:05:17Z","timestamp":1785351917080,"version":"3.55.0"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/16\/65\/32489"],"award-info":[{"award-number":["FS\/16\/65\/32489"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/62\/34593"],"award-info":[{"award-number":["PG\/19\/62\/34593"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/16\/64\/32311"],"award-info":[{"award-number":["PG\/16\/64\/32311"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Platelet-associated complications including thrombosis, thrombocytopenia, and haemorrhage are commonly observed during various inflammatory diseases such as psoriasis. Although several mechanisms that may contribute to the dysfunction of platelets during inflammatory diseases have been reported, knowledge on the primary molecules\/mechanisms that underpin platelet-associated complications in such conditions is not fully established. Here, we report the significance of the mouse antimicrobial cathelicidin, mouse cathelicidin-related antimicrobial peptide (mCRAMP) (an orthologue of LL37 in humans), on the modulation of platelet reactivity during psoriasis using Imiquimod-induced psoriasis in mice as an inflammatory disease model for psoriasis vulgaris in humans. The activation of platelets during psoriasis is increased as evidenced by the elevated levels of fibrinogen binding and P-selectin exposure on the surface of platelets, and the level of soluble P-selectin in the plasma of psoriatic mice. The skin and plasma of psoriatic mice displayed increased levels of mCRAMP. Moreover, the plasma of psoriatic mice augmented the activation of platelets obtained from healthy mice. The effect of mCRAMP is partially mediated through formyl peptide receptor 2\/3 (Fpr2\/3, the orthologue to human FPR2\/ALX) in platelets as a significant reduction in their activation was observed when FPR2\/ALX-selective inhibitors such as WRW4 or Fpr2\/3-deficient mouse platelets were used in these assays. Since the level of antimicrobial cathelicidin is increased in numerous inflammatory diseases such as psoriasis, atherosclerosis, and inflammatory bowel disease, the results of this study point towards a critical role for antimicrobial cathelicidin and FPR2\/ALX in the development of platelet-related complications in such diseases.<\/jats:p>","DOI":"10.3390\/biom10091267","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T09:29:28Z","timestamp":1599038968000},"page":"1267","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Antimicrobial Cathelicidin CRAMP Augments Platelet Activation during Psoriasis in Mice"],"prefix":"10.3390","volume":"10","author":[{"given":"Maryam F.","family":"Salamah","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Reading, Reading RG6 6UB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Vallance","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading, Reading RG6 6UB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Kodji","sequence":"additional","affiliation":[{"name":"Section of Vascular Biology &amp; Inflammation, School of Cardiovascular Medicine &amp; Sciences, King\u2019s College London, London SE1 9NH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyashree","family":"Ravishankar","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading, Reading RG6 6UB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5095-3131","authenticated-orcid":false,"given":"Harry F.","family":"Williams","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading, Reading RG6 6UB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-8342","authenticated-orcid":false,"given":"Susan D.","family":"Brain","sequence":"additional","affiliation":[{"name":"Section of Vascular Biology &amp; Inflammation, School of Cardiovascular Medicine &amp; Sciences, King\u2019s College London, London SE1 9NH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6006-6517","authenticated-orcid":false,"given":"Sakthivel","family":"Vaiyapuri","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading, Reading RG6 6UB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2133.1999.02963.x","article-title":"Clinical measures of disease severity and outcome in psoriasis: A critical appraisal of their quality","volume":"141","author":"Ashcroft","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5114\/pdia.2015.48066","article-title":"The role of antimicrobial peptides in chronic inflammatory skin diseases","volume":"33","author":"Marcinkiewicz","year":"2016","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.it.2008.12.003","article-title":"AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense","volume":"30","author":"Lai","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.peptides.2016.09.002","article-title":"Molecular mechanisms of LL-37-induced receptor activation: An overview","volume":"85","author":"Verjans","year":"2016","journal-title":"Peptides"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/bloodadvances.2018021758","article-title":"The endogenous antimicrobial cathelicidin LL37 induces platelet activation and augments thrombus formation","volume":"2","author":"Salamah","year":"2018","journal-title":"Blood Adv."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"De","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1038\/s41467-020-17699-z","article-title":"Mammalian histones facilitate antimicrobial synergy by disrupting the bacterial proton gradient and chromosome organization","volume":"11","author":"Doolin","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/biof.1225","article-title":"Unique features of human cathelicidin LL-37","volume":"41","author":"Bandurska","year":"2015","journal-title":"Biofactors"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: The role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/cei.13047","article-title":"Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease","volume":"191","author":"Kusaka","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/path.1224","article-title":"Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes","volume":"198","author":"Paulsen","year":"2002","journal-title":"J. Pathol."},{"key":"ref_16","first-page":"404","article-title":"Expression of LL-37, human beta defensin-2, and CCR6 mRNA in patients with psoriasis vulgaris","volume":"24","author":"Li","year":"2004","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1468-3083.2011.04083.x","article-title":"Circulating LL-37 is a biomarker for eczema severity in children","volume":"26","author":"Leung","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/CIRCRESAHA.112.265868","article-title":"Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice","volume":"110","author":"Drechsler","year":"2012","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.ATV.0000223901.08459.57","article-title":"Involvement of the antimicrobial peptide LL-37 in human atherosclerosis","volume":"26","author":"Edfeldt","year":"2006","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/84627","article-title":"Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator","volume":"7","author":"Islam","year":"2001","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1532\/IJH97.A10407","article-title":"Marked reduction of LL-37\/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia","volume":"81","author":"An","year":"2005","journal-title":"Int. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1523-1747.2003.12069.x","article-title":"The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium","volume":"120","author":"Heilborn","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0196-9781(01)00499-5","article-title":"Processing site and gene structure for the murine antimicrobial peptide CRAMP","volume":"22","author":"Pestonjamasp","year":"2001","journal-title":"Peptides"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"268257","DOI":"10.1155\/2014\/268257","article-title":"Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis","volume":"2014","author":"Hwang","year":"2014","journal-title":"Mediators Inflamm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-018-03925-2","article-title":"Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation","volume":"9","author":"Pircher","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1242\/jcs.01325","article-title":"Platelet adhesion signalling and the regulation of thrombus formation","volume":"117","author":"Gibbins","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2009.06.053","article-title":"Platelet activation in patients with psoriasis: Increased plasma levels of platelet-derived microparticles and soluble P-selectin","volume":"62","author":"Katoh","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/asheducation-2016.1.256","article-title":"Platelets in infectious disease","volume":"2016","author":"Middleton","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1096\/fj.201800395RR","article-title":"Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis","volume":"33","author":"Kodji","year":"2019","journal-title":"FASEB J"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jid.2018.02.040","article-title":"TRPA1 Acts in a Protective Manner in Imiquimod-Induced Psoriasiform Dermatitis in Mice","volume":"138","author":"Kodji","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood-2014-06-585083","article-title":"EphB2 regulates contact-dependent and contact-independent signaling to control platelet function","volume":"125","author":"Vaiyapuri","year":"2015","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1038\/s41598-017-05936-3","article-title":"Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy","volume":"7","author":"Ravishankar","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.0903526","article-title":"Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation","volume":"184","author":"Dufton","year":"2010","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.jid.5700286","article-title":"The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion","volume":"126","author":"Klotz","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"16570","DOI":"10.1038\/s41598-017-16707-5","article-title":"The Systemic Response to Topical Aldara Treatment is Mediated Through Direct TLR7 Stimulation as Imiquimod Enters the Circulation","volume":"7","author":"Nerurkar","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/jdv.12817","article-title":"PASI90 response: The new standard in therapeutic efficacy for psoriasis","volume":"29","author":"Puig","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/ard.2004.031237","article-title":"Psoriasis assessment tools in clinical trials","volume":"64","author":"Feldman","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/exd.13378","article-title":"Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes","volume":"26","author":"Bonifacio","year":"2017","journal-title":"Exp. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2332\/allergolint.O-08-537","article-title":"Elevated platelet activation in patients with atopic dermatitis and psoriasis: Increased plasma levels of beta-thromboglobulin and platelet factor 4","volume":"57","author":"Katoh","year":"2008","journal-title":"Allergol. Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-0625.2010.01095.x","article-title":"Platelet P-selectin reflects a state of cutaneous inflammation: Possible application to monitor treatment efficacy in psoriasis","volume":"19","author":"Garbaraviciene","year":"2010","journal-title":"Exp. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cca.2015.04.023","article-title":"Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis?","volume":"446","author":"Chandrashekar","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_42","first-page":"1326","article-title":"Production of soluble P-selectin by platelets and endothelial cells","volume":"64","author":"Semenov","year":"1999","journal-title":"Biochemistry"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10067-009-1323-8","article-title":"Mean platelet volume in psoriasis and psoriatic arthritis","volume":"29","author":"Canpolat","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MAJ.0b013e3181db6ed5","article-title":"Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test","volume":"339","author":"Magen","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1474-51510200038-5","article-title":"Platelets and cardiovascular disease","volume":"1","author":"Willoughby","year":"2002","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: Bridging inflammation and cardiovascular disease","volume":"100","author":"Weber","year":"2007","journal-title":"Circ. Res."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ahlehoff, O., Gislason, G.H., Lindhardsen, J., Charlot, M.G., J\u00f8rgensen, C.H., Olesen, J.B., Bretler, D.M., Skov, L., Torp-Pedersen, C., and Hansen, P.R. (2011). Psoriasis carries an increased risk of venous thromboembolism: A Danish nationwide cohort study. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018125"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/CIRCRESAHA.112.300666","article-title":"Neutrophil-derived cathelicidin promotes adhesion of classical monocytes","volume":"112","author":"Wantha","year":"2013","journal-title":"Circ. Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/9\/1267\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:00Z","timestamp":1760177160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/9\/1267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["biom10091267"],"URL":"https:\/\/doi.org\/10.3390\/biom10091267","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,2]]}}}